The FDA has warned that ketamine and compounded ketamine products aren’t approved to treat any psychiatric disorder. This means that they haven’t been established to become safe or powerful. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only in https://mikeu000rgu8.blogaritma.com/profile